-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pheochromocytoma and paraganglioma (PCC/PGL) are neuroendocrine tumors with inconsistent levels of catecholamines, resulting in unclear changes in their metabolism and physiology
Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases, which aims to evaluate the relationship between plasma catecholamines, body weight and glycosylated hemoglobin (HA1C)
The study is a retrospective cohort study (1999-2020)
The relationship between norepinephrine concentration and body weight and HA1C
In the multivariate MEM, when the researchers tried all catecholamines and their derivatives in the model, there was a negative correlation between norepinephrine (p<0.
It can be seen that norepinephrine and its metabolites in the plasma of PCC/PGL patients are directly related to HA1C, and there is a negative correlation between it and body weight
Norepinephrine and its metabolites in the plasma of PCC/PGL patients are directly related to HA1C, and there is a negative correlation between it and body weight
Original source:
Lauren N Krumeich.
Correlation between plasma catecholamines, weight, and diabetes in pheochromocytoma and paraganglioma
in this message